Copy Link Print Information

Ustekinumab

(Synonyms: CNTO-1275; L04AC05; TT-20)
4 Cited Publications
고객리뷰

Based on 4 publication(s) in Google Scholar

Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity: 99.83%
  • CAS No.: 815610-63-0
  • 분자량:145.63 kDa
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Ustekinumab
  • Experimental Validation Results for Ustekinumab
  • Experimental Validation Results for Ustekinumab
  • Experimental Validation Results for Ustekinumab
  • Experimental Validation Results for Ustekinumab
  • Experimental Validation Results for Ustekinumab
  • Experimental Validation Results for Ustekinumab
  • Ustekinumab Chemical Structure
    Ustekinumab Chemical Structure
CAS No.: 815610-63-0
사이즈
가격
재고
수량
Amount: USD 0.00
Please select quantity
or
or

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Ustekinumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
주변의 대리점 찾기 Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Ustekinumab

More
Customer Validation & Images
Cell Proliferation/Viability AssayIn Vivo Efficacy StudyIn Vivo Imaging
  • In Vivo Efficacy Study
  • In Vivo Imaging
  • In Vivo Efficacy Study
  • Cell Proliferation/Viability Assay

All Interleukin Related Isoforms

More
Keywords
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress 로그인
Register
Sign in to MedChemExpress
회원가입

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized IL-12 beta Protein, Human (HEK293, Fc, HY-P73160) can bind Ustekinumab. The EC50 for this effect is 13.6 ng/mL.

  • 1/16

    Flow cytometric analysis of 1×106 Jurkat cells labelling IL-12B (red) with Ustekinumab (HY-P9909). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • 1/16

    Ustekinumab purchased from MedChemExpress. Usage Cited in: Adv Mater. 2024 Dec 6:e2412429. [Abstract]

    Customer Validation
     Cascade repair probiotic gene editing system improves DSS-induced UC compared with clinical drugs. Daily change in body weight for each group, including Health, Control, 5-ASA (5-Aminosalicylic acid; 40 mg/kg; oral), vedolizumab (5 mg/kg; iv), ustekinumab (5 mg/kg; iv), infliximab (5 mg/kg; iv), and LGG-M@P, over 10 days. The above drugs were administered once every two days. Measurements of colonic tissue length in various groups on day 10. DAI changes throughout 10 days, calculated as the total of the stool consistency (0–3), fecal bleeding (0–4), and weight loss (0–4) indexes.

  • 1/16

    Ustekinumab purchased from MedChemExpress. Usage Cited in: Adv Mater. 2024 Dec 6:e2412429. [Abstract]

    Customer Validation
     Cascade repair probiotic gene editing system improves DSS-induced UC compared with clinical drugs. The groups are: Health, Control, 5-ASA (5-Aminosalicylic acid; 40 mg/kg; oral), vedolizumab (5 mg/kg; iv), ustekinumab (5 mg/kg; iv), infliximab (5 mg/kg; iv), and LGG-M@P, over 10 days. The above drugs were administered once every two days. Mice colonic sections stained with HE on day 10 following the indicated treatments.

  • 1/16

    Ustekinumab purchased from MedChemExpress. Usage Cited in: Adv Mater. 2024 Dec 6:e2412429. [Abstract]

    Customer Validation
     Cascade repair probiotic gene editing system improves DSS-induced UC compared with clinical drugs. The groups are: Health, Control, 5-ASA (5-Aminosalicylic acid; 40 mg/kg; oral), vedolizumab (5 mg/kg; iv), ustekinumab (5 mg/kg; iv), infliximab (5 mg/kg; iv), and LGG-M@P, over 10 days. The above drugs were administered once every two days. Colonic MPO levels on day 10.) Colonic TNF-α, IL-6, and IL-1β levels on day 10.

  • 1/16

    Ustekinumab purchased from MedChemExpress. Usage Cited in: Nat Immunol. 2021 Sep;22(9):1107-1117. [Abstract]

    Customer Validation
     Flow cytometry quantification of cell viability and lipid ROS of HC neutrophils cultured in vitro with 20% SLE serum supplemented with anti-CXCL11 (0.1, 1, 5 µg/ml) or Ustekinumab (0.1, 1, 10 µg/ml) for 16 hours.

  • Ustekinumab Chemical Structure
    1/16
  • Ustekinumab
  • Immobilized IL-12 beta Protein, Human (HEK293, Fc, HY-P73160) can bind Ustekinumab. The EC50 for this effect is 13.6 ng/mL.
  • Flow cytometric analysis of 1×106 Jurkat cells labelling IL-12B (red) with Ustekinumab (HY-P9909). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Alexa Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa Isotype Control (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).